Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Vela Technologies reports fall in total assets

(Sharecast News) - Early-stage technology investor Vela Technologies said in an update on Friday that its total assets, including cash, decreased by £0.64m or 9% during the December quarter, amounting to £6.18m. The AIM-traded firm said that marked a swing from the prior quarter's increase of £0.94m, or 16%, to £6.82m.

Its portfolio comprised 15 active investments, consistent with the prior quarter, and of those, two were unquoted and 13 were quoted.

Notably, Vela divested its investment in St George's Street Capital to Conduit Pharmaceuticals during the quarter, receiving 1,015,760 Conduit shares in exchange.

That investment, previously held as a financial asset, was now classified as an asset held for resale.

The fair value of Vela's investment portfolio stood at £6.17m, slightly lower than the prior quarter's value of £6.79m.

Vela said the change in the portfolio's value reflected the disposal of investments valued at approximately £40,000, resulting in a realised loss of £3,000, alongside a net unrealised decrease in fair value amounting to £0.58m.

That contrasted with the prior quarter's net unrealised gain of £1.04m.

Vela's cash balance at the end of December was £6,000, down from £30,000 at the end of the prior quarter.

As of Friday, Vela's cash balance stood at approximately £60,000.

"Much of the £0.9m+ leap forward in the value of Vela's investment portfolio in the September quarter has been reversed in the December quarter," said executive director James Normand.

"Vela's investment in EnSilica, a highly rated business, perversely fell in value by a third - though it has since recovered a good part of that drop - while Conduit's value is similarly a fraction of the price at which it listed in September."

Normand said Vela's performance and position remained impeded by the continued lack of confidence in the public markets generally, particularly in the small cap markets in which the firm is largely invested.

"Although Vela's investments are for the most part in listed stocks, there is little activity in these stocks and so their market values do not reflect our opinion of their true worth."

At 1233 GMT, shares in Vela Technologies were up 3.33% at 0.02p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Entain reprices two term loans, revises interest cost outlook
(Sharecast News) - Betting and gambling giant Entain announced the successful repricing of two of its existing 'Term Loan B' loans on Monday, along with the pricing and allocation of fungible add-ons, in a bid to optimise its financial position.
Oxford Biomedica confident as it moves away from vaccine era
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.
N Brown chairman Ron McMillan to retire
(Sharecast News) - N Brown said on Monday that chairman Ron McMillan will be retiring and stepping down from the board with effect from 30 April for personal reasons.
McCarthy out, Adshead in as Ultimate Products chair
(Sharecast News) - Ultimate Products, the parent of homeware brands including Salter and Beldray, announced a change in its leadership on Monday, with James 'Jim' McCarthy deciding to step down as non-executive chair from 31 July.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.